申请人:Schering Aktiengesellschaft
公开号:US07345075B2
公开(公告)日:2008-03-18
Benzimidazoles of general formula I
and the use of benzimidazole derivatives for the production of pharmaceutical agents for treatment and prophylaxis of diseases that are associated with a microglia activation are described.
本发明涉及一般式I的苯并咪唑化合物及其衍生物的使用,用于制备用于治疗和预防与微胶质细胞激活相关的疾病的制药剂。